Tissue factor pathway inhibitor for prediction of placenta-mediated adverse pregnancy outcomes in high-risk women: AngioPred study - Université de Montpellier Accéder directement au contenu
Article Dans Une Revue PLoS ONE Année : 2017

Tissue factor pathway inhibitor for prediction of placenta-mediated adverse pregnancy outcomes in high-risk women: AngioPred study

Résumé

The study aimed to evaluate if the rate of tissue factor pathway inhibitor during pregnancy and following delivery could be a predictive factor for placenta-mediated adverse pregnancy outcomes in high-risk women.
Fichier principal
Vignette du fichier
pone.0173596.pdf (868.46 Ko) Télécharger le fichier
pone.0181474.pdf (300.17 Ko) Télécharger le fichier
Origine Fichiers éditeurs autorisés sur une archive ouverte

Dates et versions

hal-01877092 , version 1 (25-05-2021)

Licence

Identifiants

Citer

Aurélie Di Bartolomeo, Céline Chauleur, Jean-Christophe Gris, Céline Chapelle, Edouard Noblot, et al.. Tissue factor pathway inhibitor for prediction of placenta-mediated adverse pregnancy outcomes in high-risk women: AngioPred study. PLoS ONE, 2017, 12 (3), pp.e0173596. ⟨10.1371/journal.pone.0173596⟩. ⟨hal-01877092⟩
139 Consultations
45 Téléchargements

Altmetric

Partager

Gmail Mastodon Facebook X LinkedIn More